Search Results

[Analysis of sequential chemotherapy efficacy in ovarian epithelial carcinoma, fallopian tube carcinoma and primary peritoneal carcinoma].

• Authors : Shen XY; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.; Li XP

Subjects: Fallopian Tube Neoplasms*/Fallopian Tube Neoplasms*/Fallopian Tube Neoplasms*/drug therapy ; Fallopian Tube Neoplasms*/Fallopian Tube Neoplasms*/Fallopian Tube Neoplasms*/pathology ; Peritoneal Neoplasms*/Peritoneal Neoplasms*/Peritoneal Neoplasms*/drug therapy

• Source: Zhonghua fu chan ke za zhi [Zhonghua Fu Chan Ke Za Zhi] 2024 May 25; Vol. 59 (5), pp. 383-390.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 16210370R Publication Model: Print Cited Medium:

Record details

[Analysis of factors affecting the prognosis of patients with pancreatic cancer patients with obstructive jaundice].

• Authors : Zhang L; Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China Baoding Changcheng Surgical Hospital, Baoding 071032, China.; Li M

Subjects: Jaundice, Obstructive* ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/complications ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/pathology

• Source: Zhonghua nei ke za zhi [Zhonghua Nei Ke Za Zhi] 2024 May 01; Vol. 63 (5), pp. 474-479.Publisher: Zhonghua yi xue hui Country of Publication: China NLM ID: 16210490R Publication Model: Print Cited Medium: Print ISSN: 0578-1426

Record details

[Cancer survival analysis in Tianjin, 2010 to 2016].

• Authors : Wang C; Department of Cancer Registration, Institution of Noncommunicable Disease Prevention and Control, Tianjin Center for Disease Control and Prevention, Tianjin 300011, China.; Shen CF

Subjects: Pancreatic Neoplasms*; Female ; Humans

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Apr 23; Vol. 46 (4), pp. 319-325.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Clinical Efficacy and Safety of Ixazomib-Containing Regimens in the Treatment of Patients with Multiple Myeloma].

• Authors : Chen R; Jinzhou Medical University, Jinzhou 121000, Liaoning Province, China.; Xue LG

Subjects: Glycine*/Glycine*/Glycine*/*analogs & derivatives; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Boron Compounds*/Boron Compounds*/Boron Compounds*/therapeutic use

• Source: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2024 Apr; Vol. 32 (2), pp. 483-492.Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN:

Record details

[Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer].

• Authors : Xu D; Pancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.; Tu M

Subjects: Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/surgery ; Fistula*; Male

• Source: Zhonghua wai ke za zhi [Chinese journal of surgery] [Zhonghua Wai Ke Za Zhi] 2024 Feb 01; Vol. 62 (2), pp. 147-154.Publisher: Zhonghua yi xue hui, Wai ke xue hui Country of Publication: China NLM ID: 0153611 Publication Model: Print Cited Medium: Print ISSN:

Record details

[Analysis of the Efficacy and Prognosis Factors of Acute Myeloid Leukemia with a Combination Therapy of Venetoclax].

• Authors : Ren CC; The First School of Clinical Medicine of Lanzhou University, Lanzhou 730000, Gansu Province, China.; Zhang WW

Subjects: Antineoplastic Combined Chemotherapy Protocols* ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/genetics

• Source: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2024 Feb; Vol. 32 (1), pp. 104-111.Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN:

Record details

不可切除胰腺癌的分子靶向药物治疗进展.

• Authors : 胡 润¹; 李俊蒽¹; 姚 沛¹

• Source: Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi. Feb2024, Vol. 40 Issue 2, p426-432. 7p.

Record details

[A pan-cancer analysis of TTC9A expression level and its correlation with prognosis and immune microenvironment].

• Authors : Yao Y; Department of Occupational Health and Medicine, Guangzhou 510515, China.; Liu J

Subjects: Adenocarcinoma* ; Carcinoma, Renal Cell* ; Carcinoma, Squamous Cell*

• Source: Nan fang yi ke da xue xue bao = Journal of Southern Medical University [Nan Fang Yi Ke Da Xue Xue Bao] 2024 Jan 20; Vol. 44 (1), pp. 70-82.Publisher: Nanfang yi ke da xue xue bao bian ji bu Country of Publication: China NLM ID: 101266132 Publication Model: Print Cited Medium: Print ISSN:

Record details

Mass spectrometry analysis of intact protein N -glycosylation signatures of cells and sera in pancreatic adenocarcinomas.

• Authors : Xu M; Center for Clinical Mass Spectrometry, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.; Liu Z

Subjects: Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/pathology ; Adenocarcinoma*; Humans

• Source: Journal of Zhejiang University. Science. B [J Zhejiang Univ Sci B] 2024 Jan 15; Vol. 25 (1), pp. 51-64.Publisher: Zhejiang University Press Country of Publication: China NLM ID: 101236535 Publication Model: Print Cited Medium: Internet ISSN:

Record details

胰腺肿瘤相关消化不良的诊治.

• Authors : 时国东¹; 陆子鹏¹; 蒋奎荣¹

• Source: Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi. Dec2023, Vol. 39 Issue 12, p2770-2774. 5p.

Record details